AbbVie's Phase 3 VERONA trial in HR-MDS showed no overall survival benefit for venetoclax-azacitidine; existing uses of ...

It’s been more than three years since DBV Technologies’ peanuty allergy therapy was rejected for FDA approval, but the company thinks it now has a clear route to market with its patch product ...

Ambient listening software is part of a buzzy new technology being marketed as AI “scribes,” or assistants, to help doctors ...

Incyte Corp. (INCY) announced that primary results from the Phase 3 POD1UM-303/InterAACT 2 trial of retifanlimab (Zynyz)—a humanized monoclonal antibody targeting PD-1—combined with carboplatin and ...

WASHINGTON — Brian Wilson, the Beach Boys’ visionary and fragile leader whose genius for melody, arrangements and wide-eyed ...

A new comparative study led by researchers at the UNC School of Medicine found that a new therapy for prevention of recurrent ...

WASHINGTON — Brian Wilson, the Beach Boys’ visionary and fragile leader whose genius for melody, arrangements and wide-eyed self-expression inspired “Good Vibrations,” “California Girls” and other ...